Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.

导出 LinkOut

翻译打印收藏纠错

作者： Mark Kristof,Farkas ^[1] ; Cynthia,Beller ^[2] ; Ali,Bozorg ^[2] ; Carrie,McClung ^[2] ; Robert,Roebling ^[3] ; Tanisia,Yates ^[2] ; Nancy,Yuen ^[2] ; Iryna,Makedonska ^[4]

作者单位： First Department of Pediatrics, Semmelweis University, Budapest, Hungary. ^[1] UCB Pharma, Morrisville, North Carolina, USA. ^[2] UCB Pharma, Monheim am Rhein, Germany. ^[3] Dnipro City Pediatric Clinical Hospital, Dnipro, Ukraine. ^[4]

关键词 antiseizure medication focal seizure intravenous lacosamide pediatric primary generalized tonic-clonic seizures

主题词儿童(Child);人类(Humans);乙酰胺类(Acetamides);抗惊厥药(Anticonvulsants);癫痫(Epilepsy);发作(Seizures)

DOI 10.1002/epi4.12682

PMID 36529709

发布时间 2023-03-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Epilepsia open

2023年8卷1期

146-153页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.

Epilepsia open

相似文献

Epilepsia open

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and tolerability of short-term infusions of intravenous lacosamide in pediatric patients with epilepsy: An open-label, phase 2/3 trial.

Epilepsia open

相似文献

Epilepsia open

相关期刊

检索历史清除